Type 2 diabetes: blood pressure lowering to 135/75 mm Hg reduces mortality
Einecke, D.
MMW Fortschritte der Medizin 149(38): 18
2007
ISSN/ISBN: 1438-3276 PMID: 18018407 Document Number: 606010
Document emailed within 1 workday
Related Documents
Scheen, A.J. 2015: EMPA-REG OUTCOME: Empagliflozin reduces mortality in patients with type 2 diabetes at high cardiovascular risk Revue Medicale de Liege 70(11): 583-589Baumgart, P. 2008: Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure MMW Fortschritte der Medizin 150(1-2): 52-53
Imai; Ohkubo; Sakuma; Tsuji; Satoh; Nagai; Hisamichi; Abe 1996: Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan Blood Pressure Monitoring 1(3): 251-254
Hannedouche, T.; Choukroun, G.; Delgado, A.; Boitard, C.; Lacour, B.; Grünfeld, J.P. 1990: Blood pressure changes induced by ciclosporin A in type I diabetes Mineral and Electrolyte Metabolism 16(1): 12-15
Leitão, C.Bauermann.; Canani, Lís.Henrique.; Silveiro, S.Pinho.; Gross, J.Luiz. 2007: Ambulatory blood pressure monitoring and type 2 diabetes mellitus Arquivos Brasileiros de Cardiologia 89(5): 315
Dakhli, S.; Lamine, S.; Lamine, F.; Trabelsi, N.; Aouididi, F.; Zouaoui, C.; Mami, F.Ben.; Achour, A. 2007: Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy La Tunisie Medicale 85(11): 945-950
Jarmuzewska, E.A.; Rocchi, R.; Mangoni, A.A. 2006: Predictors of impaired blood pressure homeostasis during acute and sustained orthostasis in patients with type 2 diabetes Panminerva Medica 48(1): 67-72
Kulenović, I. 2006: Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes Medicinski Arhiv 60(3): 179-181
Mosorjáková, D.; Kyslanová, L.; Kozárová, M.; Tkác, I. 2002: Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes Vnitrni Lekarstvi 48(8): 749-754
Chalmers, J.P.; Arnolda, L.F. 2003: Lowering blood pressure in 2003 Medical Journal of Australia 179(6): 306-312
Fournier, A.; Mazouz, H.; Oprisiu, R.; Achard, J.M.; Ferdnandez, L. 2001: Blood-pressure-lowering treatment Lancet 357(9257): 716-717
Budenholzer, B. 2001: Glycaemia and vascular effects of type 2 diabetes. Lowering glucose concentrations may not be of any value in itself Bmj 322(7296): 1245-6; Author Reply 1247
Rosenthal, J. 1989: Blood pressure and lipid lowering effects of terazosin Journal of Human Hypertension 3 Suppl. 2: 85-9; Discussion 90-1
Ghione, S.; Meconi, P.; Fommei, E.; Palombo, C.; Mezzasalma, L.; Pecori, F.; Moriconi, L.; Ferri, C. 1985: The blood pressure lowering effects of plasma exchange International Journal of Artificial Organs 8 Suppl. 2: 13-14
Singh, A.; Bedi, V.P. 1984: Transient paraplegia following sudden lowering of blood pressure Journal of the Indian Medical Association 82(6): 214-5 228
Astrup, J.; Bisgaard-Frantzen, H.O.; Nielsen, S.L.; Rossing, N. 1976: The blood pressure lowering effect of myocardial infarct Ugeskrift for Laeger 138(29): 1759-1761
Strandgaard, S. 1987: Cerebral ischaemia caused by overzealous blood pressure lowering Danish Medical Bulletin 34 Suppl. 1: 5-7
Chen, D.; Jin, X.; Chen, S. 1995: Captopril in improving vascular structure and lowering blood pressure Zhonghua Yi Xue Za Zhi 75(6): 355-9 383-4
Grant, P.J. 1998: Metformin reduces circulating factor VIi concentrations in patients with type 2 diabetes mellitus Thrombosis and Haemostasis 80(1): 209-210
Mudassir, H.A.; Qureshi, S.A.; Azmi, M.B.; Ahsan, M. 2018: Ethanolic seeds extract of Centratherum anthelminticum reduces oxidative stress in type 2 diabetes Pakistan Journal of Pharmaceutical Sciences 31(3 Supplary): 991-995